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October 20111232 Abstractsincreased when siRNA was complexed with PEI. The amount of siRNA
adsorbed generally appeared greater in ePET than in PTFE fabrics. Repeated
dipping of ePET in siGLO Red/PEI solution significantly increased siRNA
adsorption vs single dipping.
Conclusions: siRNA adsorption to ePET and PTFE surfaces is signif-
icantly increased if the siRNA is complexed with PEI. Preliminary data in this
study suggest that siRNA adsorbs better to ePET than PTFE. Further,
repeated dipping of ePET additionally increased adsorption of siRNA to
fabric. Thus, coating of ePETwith siRNA/PEImay be amethod to improve
graft patency.
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Introduction and objectives: Eph-B4, the receptor tyrosine kinase
that serves as the embryonic venous fate determinant, is decreased in
association with the successful adaptation of surgical vein grafts to the
arterial environment. Stimulation of Eph-B4 recovers the native phenotype.
However, the Ephrin-B2 protein, the juxtacrine ligand for Eph-B4, is not
expressed in veins; as such, the adult physiologic controller of Eph-B4 is
unknown. We explored whether the mechanosensitive integrin--1 mole-
cule is an upstream regulator of Eph-B4 signaling.
Methods: Eph-B4–positive endothelial cells and Eph-B4–negative
Cos cells transfected with wild-type or mutant W804A Eph-B4 were stim-
ulated with type I collagen and anti–integrin--1 activating antibody
(P4G11) and analyzed with Western blotting. Colocalization was deter-
mined using immunofluorescence. Unilateral external carotid artery ligation
was performed on heterozygous integrin--1 knockout (Het-B1-KO) mice.
Carotid arteries were examined on day 14 and jugular veins on days 1 and 7.
Veins from Het-B1-KO mice were placed as aortic interposition grafts into
wild-type mice and examined at day 21.
Results:Endothelial cells stimulated with collagen or P4G11 increased
Eph-B4 phosphorylation. Eph-B4 and integrin--1 colocalized on both
endothelial cells and wild-type Eph-B4 transfected Cos cells after stimula-
tion with collagen; mutant W804A Eph-B4 transfected cells were unable to
phosphorylate Eph-B4. Het-B1-KOmice that underwent unilateral ligation
of the external carotid showed aberrant vascular remodeling. Het-B1-KO
vein grafts showed approximately threefold increased neointimal thickening
compared with wild-type controls.
Conclusions: Integrin--1 is present on endothelial cells, responds to
hemodynamic forces, induces Eph-B4 signaling, and modifies vessel and
vein graft remodeling. These results connect hemodynamic forces to vein
graft adaptation through extracellular matrix interactions. Integrin--1 is an
upstream regulator of Eph-B4 signaling during vein graft adaptation and
may represent a novel therapeutic target with the potential to limit neointi-
mal hyperplasia in vein grafts.
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Introduction and objectives: A history of a contralateral amputation
as a potential predictor of outcomes after lower extremity bypass (LEB) for
critical limb ischemia (CLI) has not been studied. We sought to determine if
a prior contralateral lower extremity amputation predicts worse outcomes in
patients undergoing LEB in the remaining intact limb.
Methods: All patients undergoing infrainguinal LEB for CLI between
2003 and 2010 within the Vascular Study Group of New England (VSGNE)
were reviewed. Patients were stratified by whether they had previously
undergone a contralateral amputation before LEB. Primary end points
included major amputation and graft occlusion at 1 year postoperatively.
Secondary end points included in-hospital major adverse events and death at
1 year.
Results: Of 2636 LEB procedures, 228 (8.6%) were performed in
patients who had undergone a prior contralateral amputation. Patients with
a prior amputation compared with those without were younger (66.5 vs
68.7; P .034) and were more likely to have congestive heart failure (24.9%
vs 16.3%; P  .002), hypertension (94.4% vs 85.4%, P  .015), renal
u
mnsufficiency (26.0% vs 13.8%, P .0002), and dependence on hemodialysis
13.6% vs 6.0%, P  .0002). These patients experienced increased in-
ospital major adverse events, including myocardial infarction, congestive
eart failure, deterioration in renal function, and respiratory complications
Table). Patients with prior contralateral amputation experienced increased
ates of graft occlusion and amputation at 1 year, but there was no difference
n mortality. Multivariable analysis showed prior contralateral amputation
as an independent predictor (odds ratio [95% confidence interval]) of
mputation (1.73 [1.06-2.83] P  .027) and graft occlusion (1.93 [1.39-
.68] P  .0001) at 1 year.
able.
No prior
contralateral
amputation
Previous
contralateral
amputation P value
ost-operative
complications
Any in-hospital major
adverse event
12.5% 19.0% 0.044
MI 4.2% 8.9% 0.002
Dysrhythmia 4.4% 6.5% 0.156
CHF 3.4% 6.1% 0.044
Change in renal function 4.7% 9.0% 0.006
Respiratory 2.3% 37.5% 0.034
ne-year complication
Graft occlusion 16.7% 37.5 0.0001
Amputation 6.7% 15.9% 0.0001
Mortality 10.4% 15.8% 0.160
Conclusions: Patients with prior contralateral amputations who pres-
nt with CLI in the intact limb represent an extremely high-risk population.
hen LEB is considered in this setting, physicians and patients should
xpect increased rates of perioperative adverse events, increased rates of
-year graft occlusion, and decreased rates of limb salvage compared with
atients who do not have a contralateral amputation.
ltrasound-Guided Angioplasty of Autogenous Arteriovenous Fistu-
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Introduction and objectives: There has been an increasing awareness
f the superiority of native arteriovenous fistulas (AVFs) over prosthetic
rafts for dialysis access. Many AVFs fail to mature, however, and others
evelop stenosis while in use. There is growing experience in treating these
atients in the interventional suite with percutaneous balloon angioplasty.
hese procedures, however, are expensive and uncomfortable for the pa-
ients, are inconvenient for patients and physicians, and involve exposure to
adiation and intravenous contrast agents in patients who are often not on
ialysis. This study reviews our experience with ultrasound-guided angio-
lasty of AVFs in the office setting.
Methods: A retrospective review was performed of all patients treated
n our practice with ultrasound-guided AVF angioplasty from May 2009 to
pril 2011. The need for intervention was determined by examination and
uplex ultrasound imaging. All patients referred to the practice with failing
r nonmaturing AVFs were treated in the office under ultrasound guidance,
nless a central venous stenosis was suspected. All procedures were per-
ormed with local anesthesia by a single surgeon, and ultrasound scans
efore, during, and after the procedure ultrasounds were performed in a
ingle vascular laboratory.
Results: The study included 30 patients with 31 AVFs who underwent
5 interventions: 48 for AVFs failing to mature and 7 for stenosis in
unctioning AFVs. Patency at 90 days was 93%. Overall complication rate
as 11%. In two patients, a proximal stenosis could not be crossed, of which
ne required surgical revision and one refused further treatment and throm-
osed. There were four peri-AVF hematomas, and three of these resulted in
FV thrombosis. No patients required hospitalization or urgent surgical
ntervention, and functional fistula was achieved in 85% of patients treated
or AVF failing to mature.
Conclusions: AVF intervention can be performed safely and effectively
nder ultrasound guidance in the office setting and is a valuable tool in the
anagement of dialysis access patients.
